BKE (NYSE) files Form 144 to sell 50,000 shares via UBS (03/16/2026)

Rhea-AI Filing Summary

BKE proposed sale notice: A Form 144 filing lists a proposed sale of 50,000 shares of Common Stock through UBS Financial Services Inc. on 03/16/2026 for trading on NYSE. The filing also lists compensation-related RSU lots, including grants dated 02/01/2025 (16,400) and 01/29/2022 (7,900). Shares outstanding are shown as 51,160,000 as of 03/16/2026.

Insights

Securities Counsel

Routine Form 144 notice of proposed resale by an insider or affiliate.

The filing lists a proposed sale of 50,000 shares to be effected through UBS Financial Services Inc. on 03/16/2026. Form 144 is a notice of intent to sell restricted or control securities and does not itself consummate a transaction.

Timing, execution method, and actual proceeds are not disclosed here; the filing also itemizes compensation-related RSU lots such as 16,400 (02/01/2025) and 7,900 (01/29/2022) that are listed in the schedule. Subsequent trade reports or confirmations would show whether the sales occurred and the cash-flow treatment.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	50000	2500000	51160000	03/16/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	02/01/2025	COMPENSATION/RSU	ISSUER			16400	02/01/2025	COMPENSATION/RSU
COMMON	01/29/2022	COMPENSATION/RSU	ISSUER			7900	01/29/2022	COMPENSATION/RSU
COMMON	03/20/2023	COMPENSATION/RSU	ISSUER			3400	03/20/2023	COMPENSATION/RSU
COMMON	01/29/2016	COMPENSATION/RSU	ISSUER			6100	01/29/2016	COMPENSATION/RSU
COMMON	02/02/2008	COMPENSATION/RSU	ISSUER			6919	02/02/2008	COMPENSATION/RSU
COMMON	02/01/2020	COMPENSATION/RSU	ISSUER			9200	02/01/2020	COMPENSATION/RSU
COMMON	03/19/2007	COMPENSATION/RSU	ISSUER			81	03/19/2007	COMPENSATION/RSU

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does BKE's Form 144 report?

The filing reports a proposed resale of 50,000 shares of Common Stock through UBS Financial Services Inc. for trading on NYSE on 03/16/2026. It is a notice of intent, not a trade confirmation.

Who is the broker handling the proposed BKE sale?

The proposed sale is listed to be effected through UBS Financial Services Inc. at the address shown. The filing names UBS as the broker-dealer for the proposed transaction.

Does the Form 144 list RSUs associated with the sale?

Yes; the schedule includes compensation-related RSU lots, including 16,400 shares (02/01/2025) and 7,900 shares (01/29/2022), which are listed in the securities section.

How many shares outstanding does the filing show for BKE?

The filing shows 51,160,000 shares outstanding as of 03/16/2026. This figure is presented in the filing as a baseline context number.

Does Form 144 confirm that the sale occurred and proceeds were received?

No; the Form 144 provides a proposed sale notice. It does not confirm execution or state proceeds. Trade confirmations or subsequent filings would disclose actual sales and cash treatment.